Home/Filings/4/0000899243-21-004521
4//SEC Filing

Beaulieu Joseph 4

Accession 0000899243-21-004521

CIK 0001571498other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 9:08 PM ET

Size

7.5 KB

Accession

0000899243-21-004521

Insider Transaction Report

Form 4
Period: 2021-02-01
Beaulieu Joseph
Corporate Controller
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-01+11,55011,550 total
    Exercise: $11.02Exp: 2031-01-31Common Stock (11,550 underlying)
  • Award

    Common Stock

    2021-02-01+7,70013,658 total
Footnotes (2)
  • [F1]Consists of shares of Common Stock issuable under 7,700 restricted stock units ("RSUs") granted pursuant to the Company's 2013 Stock Incentive Plan. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in four equal annual installments over four years from the grant date, with the first installment vesting on February 1, 2022.
  • [F2]This option was granted on February 1, 2021 pursuant to the Company's 2013 Stock Incentive Plan with respect to 11,550 shares of Common Stock, with 25% vesting on February 1, 2022 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeother

Related Parties

1
  • filerCIK 0001766032

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 9:08 PM ET
Size
7.5 KB